Biological Treatment of Triclosan using a Novel Strain of Enterobacter cloacae and Introducing Naphthalene Dioxygenase as an Effective Enzyme

In recent years, triclosan (TCS) has been widely used as an antibacterial agent in personal care products due to the spread of the Coronavirus. TSC is an emerging contaminant, and due to its stability and toxicity, it cannot be completely degraded through traditional wastewater treatment methods. In this study, a novel strain of Enterobacter cloacae was isolated and identified that can grow in high TCS concentrations. Also, we introduced naphthalene dioxygenase as an effective enzyme in TCS biodegradation, and its role during the removal process was investigated along with the laccase enzyme. The change of cell surface hydrophobicity during TCS removal revealed that a glycolipid biosurfactant called rhamnolipid was involved in TCS removal, leading to enhanced biodegradation of TCS. The independent variables, such as initial TCS concentration, pH, removal duration, and temperature, were optimized using the response surface method (RSM). As a result, the maximum TCS removal (97%) was detected at a pH value of 7 and a temperature of 32 °C after 9 days and 12h of treatment. Gas chromatography-mass spectrometry (GC/MS) analysis showed five intermediate products and a newly proposed pathway for TCS degradation. Finally, the phytotoxicity experiment conducted on Cucumis sativus and Lens culinaris seeds demonstrated an increase in germination power and growth of stems and roots in comparison to untreated water. These results indicate that the final treated water was less toxic.

Biosurfactant: A Biodegradable Antimicrobial Substance

The coronavirus pandemic in 2020 increased the use of cleaning agents by residential individuals and businesses that maintained their operation even remotely. In formulating these products, one of the key ingredients is the surfactant molecule. Surfactants, in general, due to their characteristics, can act as antimicrobial agents. The presence of this active in cleaning products facilitates the process of removing dirt and reduces the occurrence of infections and health risks. However, most surfactants present in the consumer market, when used, require high consumption of water for removal and are also discharged into domestic sewage, without treatment, causing toxicity in different organisms due to their recalcitrance in the environment. Thus, the knowledge and use of biosurfactants, amphipathic molecules that can be obtained by plants and microbes, is important. Since, in addition to the same properties found in common surfactants, biosurfactants are highly biodegradable. This chapter discusses biosurfactants with a focus on their biodegradability, the different types of tests applied to assess this parameter and recent studies with importance in the applications of biosurfactants as antimicrobial agents. © 2022 Scrivener Publishing LLC.

Biosurfactants in respiratory viruses and the Coronavirus disease 2019 pandemic

The world is facing one of its largest Pandemics ever, “The COVID-19”! The giant leaps taken in medicine and research have bowed down before a teeny tiny virus. This has conveyed to mankind that the armamentariums we possess against viruses are futile. Most of the drugs provide symptomatic relief only with few unswervingly being able to destroy the virus. Nonetheless, the scientific community is on the overtime for new boulevards of research and ways to defeat this threat. Biosurfactants (BSs) were stumbled upon as a plausible gold mine! In fact, its antimicrobial and antiadhesive properties have been well accepted. It is now postulated to be of aid in preventing the spread of viruses, that is, as a disinfecting agent, as an antiviral by curing symptoms occurring in the incubation period, killing directly the virus-infected cells and also as a drug delivery system. This chapter aims to provide an insight into what BSs are and their enormous potentials in dealing with Respiratory viruses especially the severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). © 2022 Elsevier Inc. All rights reserved.

Biosurfactants in the sustainable eradication of SARS COV-2 from the environmental surfaces.

The COVID-19 outbreak has brought the world, at least, to one consensus that cleanliness is unavoidable under all circumstances. Hands are the main body part to interact with the environment and thus are prone to receive, initiate and propagate the chain of infection. Hand hygiene has, therefore, been most emphasized by experts to interrupt the spread of infection. Various harsh chemicals like synthetic surfactants and alcoholic preparations have been in practice to eradicate and disinfect the germs. This choice may be unsafe and cause a subsequent chain of adversities. Thereby, biosurfactants have been proposed as sustainable, non-toxic and safe surface cleaners cum disinfectants under a wide range of physiological and environmental conditions. The amphiphilic micellar behavior of biosurfactants makes them promising candidates as hygienic surface cleaners and therapeutic carriers. We overview the possibilities of using biosurfactants in different ways against microbial pathogens, in general, and the SARS COV-2, in specific.

Current advances in the classification, production, properties and applications of microbial biosurfactants - A critical review.

This review discusses the classification, characteristics, and applications of biosurfactants. The biosynthesis pathways for different classes of biosurfactants are reviewed. An in-depth analysis of reported research is carried out emphasizing the synthetic pathways, culture media compositions, and influencing factors on production yield of biosurfactants. The environmental, pharmaceutical, industrial, and other applications of biosurfactants are discussed in detail. A special attention is given to the biosurfactants application in combating the pandemic COVID-19. It is found that biosurfactant production from waste materials can play a significant role in enhancing circular bioeconomy and environmental sustainability. This review also details the life cycle assessment methodologies for the production and applications of biosurfactants. Finally, the current status and limitations of biosurfactant research are discussed and the potential areas are highlighted for future research and development. This review will be helpful in selecting the best available technology for biosynthesis and application of particular biosurfactant under specific conditions.

Potential of Bacillus subtilis Against SARS-CoV-2 - A Sustainable Drug Development Perspective.

The COVID-19 pandemic had anomalous yet inevitable impacts on the world's economies, healthcare systems, and all other aspects of life. Researchers began to uncover hidden routes to find a new horizon of hope using underrated resources. Biosurfactants are sustainable biomolecules with an active surface, unique characteristics, and extensive uses. Bacillus species showed the highest amount of biosurfactant activities and Bacillus subtilis is one of them. The antiviral, antimicrobial, and anti-inflammatory activity of B. subtilis was proven recently. The great advantage is its non-toxic nature. Pro-inflammatory cytokines including IL-1 ß, 6, 8, 12, 18, and TNF-(α are secreted in higher amounts when neutrophils and monocytes are triggered by biosurfactant bacteria. This point of view furnishes the potential application of B. subtilis and its biomolecules against COVID-19, either in the form of a vaccine/therapeutic agent, for a greener environment, healthier life, and environmental sustainability. Further in vivo and clinical trials are needed to validate this hypothesis.

Sophorolipid: a glycolipid biosurfactant as a potential therapeutic agent against COVID-19.

Biosurfactants are natural surfactants produced by a variety of microorganisms. In recent years, biosurfactants have garnered a lot of interest due to their biomedical and pharmaceutical applications. Sophorolipids are glycolipid types of biosurfactants produced by selected nonpathogenic yeasts. In addition to the detergent activity (reduction in surface and interfacial tension), which is commonly utilized by biomedical applications, sophorolipids have shown some unique properties such as, antiviral activity against enveloped viruses, immunomodulation, and anticancer activity. Considering their antiviral activity, the potential of sophorolipids as an antiviral therapy for the treatment of COVID-19 is discussed in this review. Being a surfactant molecule, sophorolipid could solubilize the lipid envelope of SARS-CoV-2 and inactivate it. As an immunomodulator, sophorolipid could attenuate the cytokine storm caused by the SARS-CoV-2 upon infection, and inhibit the progression of COVID-19 in patients. Sophorolipids could also be used as an effective treatment strategy for COVID-19 patients suffering from cancer. However, there is limited research on the use of sophorolipid as a therapeutic agent for the treatment of cancer and viral diseases, and to modulate the immune response. Nevertheless, the multitasking capabilities of sophorolipids make them potential therapeutic candidates for the bench-to-bedside research for the treatment of COVID-19.

Combining OSMAC Approach and Untargeted Metabolomics for the Identification of New Glycolipids with Potent Antiviral Activity Produced by a Marine Rhodococcus.

Natural products of microbial origin have inspired most of the commercial pharmaceuticals, especially those from Actinobacteria. However, the redundancy of molecules in the discovery process represents a serious issue. The untargeted approach, One Strain Many Compounds (OSMAC), is one of the most promising strategies to induce the expression of silent genes, especially when combined with genome mining and advanced metabolomics analysis. In this work, the whole genome of the marine isolate Rhodococcus sp. I2R was sequenced and analyzed by antiSMASH for the identification of biosynthetic gene clusters. The strain was cultivated in 22 different growth media and the generated extracts were subjected to metabolomic analysis and functional screening. Notably, only a single growth condition induced the production of unique compounds, which were partially purified and structurally characterized by liquid chromatography high-resolution tandem mass spectrometry (LC-HRMS/MS). This strategy led to identifying a bioactive fraction containing >30 new glycolipids holding unusual functional groups. The active fraction showed a potent antiviral effect against enveloped viruses, such as herpes simplex virus and human coronaviruses, and high antiproliferative activity in PC3 prostate cancer cell line. The identified compounds belong to the biosurfactants class, amphiphilic molecules, which play a crucial role in the biotech and biomedical industry.